Clinitech Laboratory Ltd IPO

NABL Accreditation.

Chain of Diagnostic Centers.

Experienced Promoter and management team with strong industry expertise and successful track record.

Strong and long-standing customer relationships.

Its business and prospects may be adversely affected if the company is unable to maintain and grow its brand name and brand image.

Any inability on its part to maintain quality standards could adversely impact its business, results of operations and financial condition.

The company does not own its Registered Office and diagnostic centres from which the company operates.

The company has in the past entered into related party transactions and may continue to do so in the future, which may potentially involve conflicts of interest with the equity shareholders.

The company has experienced negative cash flows in the past. Any such negative cash flows in the future could adversely affect its business, results of operations and prospects.

The company depends on skilled personnel and if its unable to recruit and retain skilled personnel, the companys ability to operate or grow its business could be affected.

Its operations are concentrated in Thane and Navi Mumbai, and any loss of business in such region could have an adverse effect on its business, results of operations and financial condition.

Substantial portion of its purchases has been dependent upon limited number of vendors/ suppliers.

The Company has allotted Equity Shares during the preceding one year from the date of the Prospectus which are lower than the Issue Price.

The company has not entered into long-term contracts with its customers and typically operates on the basis of orders from its walk-in customers, any loss of customers could adversely impact its revenues and profitability.